Epicardial Versus Transvenous Implantable Cardioverter Defibrillators in Children
Epicardial Versus Transvenous Implantable Cardioverter Defibrillators in Children
This observational study included all patients <18-year-old implanted with an Implantable cardioverter defibrillator (ICD) at Necker Hospital, Paris, France, from January 2003 to January 2021. Outcomes (ICD-related complications and reinterventions) were compared between epicardial and transvenous ICDs using Cox proportional hazard models.
Inclusion Criteria:
Exclusion Criteria:
- Absence of patient's consent